AviClear® vs. Accutane: A Clear Comparison

If you’ve researched serious acne treatment, you’ve met both of these names: Accutane (isotretinoin), the powerful oral medication that’s been a mainstay for decades, and AviClear®, the newer laser that treats acne at the source. They’re often framed as rivals, but they’re really very different tools — one a systemic medication, one an in-clinic device.

The one-paragraph summary

Accutane (isotretinoin) is the most effective acne treatment available and can produce long-term remission, but it’s a systemic medication with significant side effects, strict pregnancy precautions, and required monitoring. AviClear is a laser that reduces oil production with no systemic side effects and no pregnancy restrictions, works across all skin tones, and doesn’t depend on daily pills — but it’s newer (less long-term data), costs out of pocket, and may not match isotretinoin for the most severe acne. Neither is universally “better”; the right choice depends on your acne and your priorities.

How each one works

Accutane (isotretinoin) is an oral retinoid — a vitamin A derivative taken daily for a course of several months. It’s uniquely powerful because it hits all four drivers of acne at once: it dramatically shrinks oil glands and sebum production, normalizes skin-cell turnover, reduces acne bacteria, and calms inflammation. This is why it can clear even severe acne and, for many people, keep it gone long-term.

AviClear is a 1726 nm laser delivered in a series of (typically three) in-clinic sessions. It targets one driver — the sebaceous glands — heating and downregulating them to reduce oil production at the source. So both reduce oil, but isotretinoin works more broadly and systemically, while AviClear works locally on the treated skin.

Effectiveness

Accutane is widely regarded as the gold standard for severe, nodular, and treatment-resistant acne, with decades of evidence. For many patients a single course produces lasting clearance — sometimes a functional cure. No other single treatment matches its track record for severe acne.

AviClear has encouraging peer-reviewed data: in its pivotal study, the share of patients achieving at least a 50% reduction in inflammatory lesions rose to roughly 80% at 12 weeks and 87% at 26 weeks, with results that kept improving over the first year. It’s effective for mild-to-severe inflammatory acne, but it’s newer, has less long-term data, and for the most severe nodulocystic acne, isotretinoin may still have the edge.

Side effects and safety

This is where the two differ most sharply.

Accutane (isotretinoin)

• Teratogenicity is the defining risk: it causes severe birth defects, so it must never be taken during pregnancy. In the U.S., it’s dispensed only through the iPLEDGE program, which requires pregnancy testing and two forms of contraception.
• Near-universal dryness of lips, skin, eyes, and nose.
• Possible muscle and joint aches, sun sensitivity, and elevated blood lipids/liver enzymes — requiring periodic blood tests.
• Reported mood changes; monitoring for depression or mood symptoms is standard, even as the causal relationship remains debated.
• Requires ongoing clinician supervision throughout the course.

AviClear

• No systemic side effects — it’s a local treatment, so no blood tests, no pills, no effect on the rest of the body.
• No pregnancy-related contraindication of the same kind (though treatment is generally avoided during pregnancy as a precaution, and it’s contraindicated during skin cancer treatment).
• Side effects are usually mild and temporary: discomfort during treatment, brief redness, a possible transient acne flare, and dryness.
• Safe across all skin tones.

Treatment experience and time

• Accutane: a daily oral pill for typically 4–6 months, with regular clinic visits and blood tests, plus iPLEDGE requirements. Some experience an initial flare.
• AviClear: usually three in-clinic sessions (about 30 minutes each) spaced a few weeks apart, with minimal downtime. Results build gradually over months.

Cost and access

• Accutane is often at least partly covered by insurance, as it’s a prescription medication for a medical condition — though it requires the iPLEDGE program and monitoring visits.
• AviClear is generally not covered by insurance (considered cosmetic/elective) and paid out of pocket as a package, making its upfront cost higher.

Who might choose which

Accutane may be the better fit if you have severe, scarring, nodulocystic, or treatment-resistant acne; want the most powerful, most evidence-backed option; are able and willing to follow iPLEDGE, contraception, and monitoring requirements; or prefer a treatment more likely to be insurance-covered.

AviClear may be the better fit if you want to avoid systemic medication or can’t take isotretinoin; are pregnant-capable and want to avoid isotretinoin’s pregnancy-prevention requirements; have struggled with medication side effects or don’t want daily pills and blood tests; want a melanin-safe option; or have mild-to-severe inflammatory acne and value a localized approach. These aren’t always either/or — a clinician might sequence or combine approaches over time.

The bottom line

Accutane remains the most powerful acne treatment we have, especially for severe disease, but it’s a serious systemic medication with real requirements and risks. AviClear offers a fundamentally different trade-off: a localized, systemic-side-effect-free, all-skin-tone option with promising (if newer) evidence, at a higher out-of-pocket cost. The “winner” genuinely depends on your acne severity, your tolerance for medication and monitoring, your pregnancy considerations, and your budget.